FDA Approved: DAURISMO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for DAURISMO (glasdegib) filed by Pfizer Laboratories Div Pfizer Inc, resulting in an updated labeling/ indication r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Daurismo (glasdegib)

Snippet

SUPPL AP for DAURISMO (GLASDEGIB)